Director/PDMR Shareholding

By

Regulatory News | 16 Dec, 2024

Updated : 07:01

RNS Number : 1032Q
RIT Capital Partners PLC
16 December 2024
 

RIT CAPITAL PARTNERS PLC ("Company")

LEI: P31Q1NLTW35JJGHA4667

           

NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

The information set out below is provided by the Company in accordance with the UK version of the EU Market Abuse Regulation No 596/2014.

 

1

Details of the person discharging managerial responsibilities ("PDMR")/person closely associated ("PCA")

a)

Name

Helena Coles

2

Reason for the notification

a)

Position/status

A Director of the Company

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

RIT Capital Partners plc

b)

LEI

P31Q1NLTW35JJGHA4667

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of £1.00 each in RIT Capital Partners plc ("Shares") 


ISIN number GB0007366395       

b)

Nature of the transaction

Purchase of Shares

c)

Price(s) and volume(s)

Price

Volume

1,996p

1,002

d)

Aggregated information

 

Not applicable - a single transaction

e)

Date of the transaction

13 December 2024

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

For more information:

J. Rothschild Capital Management (Manager):

T: 020 7647 8565

E: investorrelations@ritcap.co.uk

 

Numis (Joint Broker):

David Benda

T: 020 7260 1000

 

JP Morgan Cazenove (Joint Broker):

William Simmonds

T: 020 3493 8000

 

Brunswick Group LLP (Media enquiries):

Nick Cosgrove

T: 020 7404 5959

E: RIT@BrunswickGroup.com 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFFLFMDELSEFE

Last news